Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.

The Pathophysiology of Gestational Diabetes Mellitus

Open access
Plows, Jasmine F, Stanley, Joanna L, Baker, Philip N, Reynolds, Clare M, Vickers, Mark H · 2018 · International Journal of Molecular Sciences

Abstract

Review of risk factors and maternal and child consequences of gestational diabetes mellitus.

Overview

CoChat Summary

TL;DR

This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.

Key findings

  • GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
  • The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
  • In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
  • The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.

Methods

  • This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
  • The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
  • The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).

Limitations

  • The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
  • The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
  • It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/ijms19113342

Cites

163 of 163 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Simplified diagram of insulin signaling. Binding of insulin to the insulin receptor (IR) activates IRS-1. Adiponectin promotes IRS-1 activation through AMP-activated protein kinase (AMPK), while pro-inflammatory cytokines activate protein kinase C (PKC) via IκB kinase (IKK), which inhibits IRS-1. IRS-1 activates phosphatidylinositol-3-kinase (PI3K), which phosphorylates phosphatidylinositol-4, 5-bisphosphate (PIP2) to phosphatidylinositol-3, 4, 5-phosphate (PIP3). PIP3 activates Akt2, which promotes GLUT4 translocation and glucose uptake into the cell.
Figure 1 Simplified diagram of insulin signaling. Binding of insulin to the insulin receptor (IR) activates IRS-1. Adiponectin promotes IRS-1 activation through AMP-activated protein kinase (AMPK), while pro-inflammatory cytokines activate protein kinase C (PKC) via IκB kinase (IKK), which inhibits IRS-1. IRS-1 activates phosphatidylinositol-3-kinase (PI3K), which phosphorylates phosphatidylinositol-4, 5-bisphosphate (PIP2) to phosphatidylinositol-3, 4, 5-phosphate (PIP3). PIP3 activates Akt2, which promotes GLUT4 translocation and glucose uptake into the cell.CC BY · PubMed Central
Figure 2 β-cell, blood glucose, and insulin sensitivity during normal pregnancy and GDM. During normal pregnancy, β-cells undergo hyperplasia and hypertrophy in order to meet the metabolic demands of pregnancy. Blood glucose rises as insulin sensitivity falls. Following pregnancy, β-cells, blood glucose, and insulin sensitivity return to normal. During gestational diabetes, β-cells fail to compensate for the demands of pregnancy, and, when combined with reduced insulin sensitivity, this results in hyperglycemia. Following pregnancy, β-cells, blood glucose, and insulin sensitivity may return to normal or may remain impaired on a pathway toward GDM in future pregnancy or T2DM. Pancreas image obtained from The Noun Project under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/), by artist Arif Fajar Vulianto.
Figure 2 β-cell, blood glucose, and insulin sensitivity during normal pregnancy and GDM. During normal pregnancy, β-cells undergo hyperplasia and hypertrophy in order to meet the metabolic demands of pregnancy. Blood glucose rises as insulin sensitivity falls. Following pregnancy, β-cells, blood glucose, and insulin sensitivity return to normal. During gestational diabetes, β-cells fail to compensate for the demands of pregnancy, and, when combined with reduced insulin sensitivity, this results in hyperglycemia. Following pregnancy, β-cells, blood glucose, and insulin sensitivity may return to normal or may remain impaired on a pathway toward GDM in future pregnancy or T2DM. Pancreas image obtained from The Noun Project under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/), by artist Arif Fajar Vulianto.CC BY · PubMed Central
Figure 3 Organs involved in the pathophysiology of GDM (Images in this figure were obtained from The Noun Project under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Brain and Gut by Hunotika; Liver by Lavmik; Pancreas by Arif Fajar Vulianto; Placenta by Charmeleon Design; Muscle by Misha Petrishchev).
Figure 3 Organs involved in the pathophysiology of GDM (Images in this figure were obtained from The Noun Project under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Brain and Gut by Hunotika; Liver by Lavmik; Pancreas by Arif Fajar Vulianto; Placenta by Charmeleon Design; Muscle by Misha Petrishchev).CC BY · PubMed Central

Verification

Claims the paper makes

40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations

81 more claims · 18 with their cited sources checked

Create a free account to see all 152 claims and to verify the 30 references still open.

See all claims — free account
  • Probably not a substantial claim. 19
  • It may state two separate claims as one. 54

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 175 references

Research works printed but not linked: 1

  1. Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].

Cited by

See all 1,874

Metadata

Authors
Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
Affiliations
  • University of Southern California (US)
  • University of Auckland (NZ)
  • University of Leicester (GB)
Corresponding author
Vickers, Mark H
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2018-10-26
Volume
19
Issue
11
Pages
3342
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2898266729
Cited by
1,874
References
175
Citations by year
2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
FWCI
15.21
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UEA Digital Repository (University of East Anglia) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
Keywords
gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
MeSH terms
Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Pathophysiology of Gestational Diabetes Mellitus. https://app.cochat.ai/papers/10.3390/ijms19113342
The paper
Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H. (2018). The Pathophysiology of Gestational Diabetes Mellitus. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms19113342

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.